sustainability

$23 Billion California Research Proposal Sidetracked; Prospects of Anti-Trump Measure Dimmed

State budget turmoil may decide the plan's fate.

Apr 29 • David Jensen

An Epilepsy Therapy and a $1 Billion Validation for California's Stem Cell Research Agency

Celebration time in South San Francisco, home to both CIRM and Neurona Therapeutics

Apr 21 • David Jensen

Will California Spend Nearly $1 Billion a Year on Stem Cell and Gene Therapy Research?

An influential advocate is calling on CIRM to double the amount it awards scientists.

Apr 2 • David Jensen

Capitol Weekly Publishes on California Stem Cell Agency's Landmark Approval of First Gene Therapy

Capitol Weekly, the respected California online news service, published a piece yesterday about the state stem cell’s agency’s first-ever approved gene…

Apr 1 • David Jensen

Great News for CIRM on Its First Therapy, Less So for the Stock Price of the Company Behind the Gene Treatment

A look at media coverage of the gene treatment approval and its implication

Mar 27 • David Jensen

California's Multibillion-Dollar Tussle Over Genetic and Stem Cell Research: How the Cash is Handed Out

Resolution perhaps on Thursday; policy priorities, scientific merit and more at stake

Mar 23 • David Jensen

Bad Knees? A California-Stem-Cell-Treatment-First is 'Running' to the Rescue...or at least to Clinical Trials

Research was backed by $10 million from CIRM

Mar 17 • David Jensen

University of California Endorses $23 Billion Research Measure That Could Put CIRM in a Financial Pickle

Hearing on the state bond proposal is scheduled in state Senate March 25

Mar 12 • David Jensen

Winners, Losers and the California Gatekeepers for Billions in Genetic Research Awards: New Standards to be Approved by CIRM

Stem cell award criteria also on the table March 19 and March 26

Mar 9 • David Jensen

Prasad Out at FDA Following Wave of Bad News About Rare Disease Treatment Approvals

His departure could boost hopes of CIRM recipient Capricor for Duchenne MS therapy go ahead.

Mar 7 • David Jensen

California's Multibillion-Dollar Tussle over How Genetic and Stem Cell Research Funding Decisions are Made

Major changes are looming this week involving the state's research agency. Will they lead to therapies that resonate with voters?

Mar 2 • David Jensen

A California Question: How to Turn Billions of Dollars into Revolutionary Gene and Stem Cell Therapies?

Complaints about CIRM's priorities and preferences to be discussed in Sacramento in late March

Feb 10 • David Jensen

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts